We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Middle-East Countries Share Health Data

By HospiMedica staff writers
Posted on 08 Jul 2008
Print article
A new system will allow public health officials in Israel, Jordan, and the Palestinian Authority to share and exchange health data, to protect patient privacy, and to monitor and react to potential disease outbreaks across geographic and political boundaries. The system currently focuses on common food-borne diseases, such as Salmonella, Shigella, and Helicobacter, which are regional problems. Avian flu will be added to the system later.

The technology used for this system standardizes the method of sharing health information and automates the task of analyzing for outbreaks. The IBM Haifa Research Lab (Haifa, Israel) and IBM's (Armonk, NY, USA) Almaden Research Center (San Jose, CA, USA) created the secure, web-based portal system, called Public Health Information Affinity Domain (PHIAD), in collaboration with the global organization Nuclear Threat Initiative's Global Health and Security Initiative (GHSI), and the regional organization Middle East Consortium on Infectious Disease Surveillance (MECIDS).

MECIDS, whose members include Israel, Jordan, and the Palestinian Authority, will be an early adopter of the technology. Currently members of MEDICS exchange information mostly on paper. By moving to a standards-based model of secure electronic information exchange, members will be able to share and exchange key data to monitor and respond to potential outbreaks.

PHIAD has already been deployed in Israel and is in place with the Palestinian Authority. Shipping has been ordered for Jordan and it [is] ready for them to use, explained Boaz Carmeli, spokesperson for the IBM Haifa Research Lab. Technically, there [is] no problem for other countries to be included.


Related Links:
The IBM Haifa Research Lab
IBM Almaden Research Center
IBM
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
Urology Table
CFLU401
New
EMR-Ready Baby Scale with WLAN Function
seca 333 i

Print article

Channels

Critical Care

view channel
Image: The microfluidic chip analyzes the chemotactic migration behaviors of neutrophils in sepsis patients (Talanta, 2024; DOI: 10.1016/j.talanta.2024.126801)

Microfluidic Chip Method to Improve Sepsis Diagnosis, Progression Evaluation and Prognosis Monitoring

Sepsis, a severe and life-threatening condition, results from an uncontrolled immune response that can lead to multi-organ failure. Given its high mortality rate and the limitations of current diagnostic... Read more

Surgical Techniques

view channel
Image: Illustration of how the razor-sharp flakes of graphene line up together on a surface and can kill bacteria without harming healthy human cells (Photo courtesy of Yen Sandqvist)

Ultra-Thin Graphene-Based Coating Material Paves Way for Bacteria-Killing Medical Devices

Healthcare-associated infections are a significant global issue, leading to immense suffering, increased healthcare costs, and a greater risk of antibiotic resistance. These infections often occur when... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Point of Care

view channel
The Atellica VTLi Patient-side Immunoassay Analyzer, a high-sensitivity troponin I test at the bedside, delivers accurate results in just 8 minutes (Photo courtesy of Siemens Healthineers)

New 8-Minute Blood Test to Diagnose or Rule Out Heart Attack Shortens ED Stay

Emergency department overcrowding is a significant global issue that leads to increased mortality and morbidity, with chest pain being one of the most common reasons for hospital admissions.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.